Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 8(1): 2736, 2018 02 09.
Article in English | MEDLINE | ID: mdl-29426874

ABSTRACT

The hypothalamic neurohormone oxytocin decreases food intake via largely unexplored mechanisms. We investigated the central nervous mediation of oxytocin's hypophagic effect in comparison to its impact on the processing of generalized rewards. Fifteen fasted normal-weight, young men received intranasal oxytocin (24 IU) or placebo before functional magnetic resonance imaging (fMRI) measurements of brain activity during exposure to food stimuli and a monetary incentive delay task (MID). Subsequently, ad-libitum breakfast intake was assessed. Oxytocin compared to placebo increased activity in the ventromedial prefrontal cortex, supplementary motor area, anterior cingulate, and ventrolateral prefrontal cortices in response to high- vs. low-calorie food images in the fasted state, and reduced calorie intake by 12%. During anticipation of monetary rewards, oxytocin compared to placebo augmented striatal, orbitofrontal and insular activity without altering MID performance. We conclude that during the anticipation of generalized rewards, oxytocin stimulates dopaminergic reward-processing circuits. In contrast, oxytocin restrains food intake by enhancing the activity of brain regions that exert cognitive control, while concomitantly increasing the activity of structures that process food reward value. This pattern points towards a specific role of oxytocin in the regulation of eating behaviour in humans that might be of relevance for potential clinical applications.


Subject(s)
Eating/drug effects , Gyrus Cinguli/physiology , Motor Cortex/physiology , Oxytocin/physiology , Prefrontal Cortex/physiology , Administration, Intranasal , Adult , Brain Mapping/methods , Cognition/drug effects , Fasting , Gyrus Cinguli/ultrastructure , Healthy Volunteers , Humans , Magnetic Resonance Imaging/methods , Male , Motivation/drug effects , Motor Cortex/ultrastructure , Oxytocin/administration & dosage , Prefrontal Cortex/ultrastructure , Reward
2.
Neurobiol Aging ; 54: 170-174, 2017 06.
Article in English | MEDLINE | ID: mdl-28385552

ABSTRACT

Aging is associated with increases in hypothalamic-pituitary-adrenal (HPA) axis activity that can predispose to metabolic and cognitive impairments. We investigated in elderly and young subjects whether intranasal insulin administration to the human brain reduces early-sleep nadir concentrations of adrenocorticotropin and cortisol, that is, indicators of baseline HPA axis activity. In within-subject comparisons, intranasal insulin (160 IU) or placebo was administered to 14 elderly (mean age 70.0 years) and 30 young (23.6 years) healthy subjects before bedtime. Sleep was polysomnographically assessed and blood samples were repeatedly collected. Elderly compared with young participants displayed increased early-sleep cortisol concentrations (p < 0.04) and reductions in slow wave and REM sleep (p < 0.001). Insulin administration reduced cortisol levels between 2300 hours and 0020 hours in the elderly (p = 0.03) but not young participants (p = 0.56; p = 0.003 for interaction). Findings indicate that central nervous insulin acts as an inhibitory signal in basal HPA axis activity regulation and suggest that intranasal insulin may normalize sleep-associated stress axis activity in older age.


Subject(s)
Aging/physiology , Hydrocortisone/blood , Insulin/administration & dosage , Insulin/pharmacology , Sleep/physiology , Administration, Intranasal , Adrenocorticotropic Hormone/blood , Adult , Aged , Cross-Over Studies , Double-Blind Method , Humans , Hypothalamo-Hypophyseal System/drug effects , Hypothalamo-Hypophyseal System/physiology , Pituitary-Adrenal System/drug effects , Pituitary-Adrenal System/physiology , Polysomnography , Young Adult
3.
Psychoneuroendocrinology ; 39: 194-203, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24120269

ABSTRACT

Oxytocin is an evolutionarily highly preserved neuropeptide that contributes to the regulation of social interactions including the processing of facial stimuli. We hypothesized that its improving effect on social approach behavior depends on perceived sexual features and, consequently, on sexual orientation. In 19 homosexual and 18 heterosexual healthy young men, we investigated the acute effect of intranasal oxytocin (24IU) and placebo, respectively, on the processing of social stimuli as assessed by ratings of trustworthiness, attractiveness and approachability for male and female faces. Faces were each presented with a neutral, a happy, and an angry expression, respectively. In heterosexual subjects, the effect of oxytocin administration was restricted to a decrease in ratings of trustworthiness for angry female faces (p<0.02). In contrast, in homosexual men oxytocin administration robustly increased ratings of attractiveness and approachability for male faces regardless of the facial expression (all p ≤ 0.05), as well as ratings of approachability for happy female faces (p<0.01). Results indicate that homosexual in comparison to heterosexual men display higher sensitivity to oxytocin's enhancing impact on social approach tendencies, suggesting that differences in sexual orientation imply differential oxytocinergic signaling.


Subject(s)
Emotions/drug effects , Heterosexuality/drug effects , Homosexuality/drug effects , Oxytocin/administration & dosage , Social Perception , Administration, Intranasal , Adult , Facial Expression , Heterosexuality/psychology , Homosexuality/psychology , Humans , Interpersonal Relations , Male , Photic Stimulation
4.
Diabetes ; 61(4): 782-9, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22344561

ABSTRACT

The role of brain insulin signaling in the control of food intake in humans has not been thoroughly defined. We hypothesized that the hormone contributes to the postprandial regulation of appetite for palatable food, and assessed the effects on appetite and snack intake of postprandial versus fasted intranasal insulin administration to the brain in healthy women. Two groups of subjects were intranasally administered 160 IU insulin or vehicle after lunch. Two hours later, consumption of cookies of varying palatability was measured under the pretext of a taste test. In a control study, the effects of intranasal insulin administered to fasted female subjects were assessed. Compared with placebo, insulin administration in the postprandial but not in the fasted state decreased appetite as well as intake and rated palatability of chocolate chip cookies (the most palatable snack offered). In both experiments, intranasal insulin induced a slight decrease in plasma glucose but did not affect serum insulin concentrations. Data indicate that brain insulin acts as a relevant satiety signal during the postprandial period, in particular reducing the intake of highly palatable food, and impacts peripheral glucose homeostasis. Postprandial intranasal insulin administration might be useful in curtailing overconsumption of snacks with accentuated rewarding value.


Subject(s)
Appetite/drug effects , Eating/drug effects , Insulin/administration & dosage , Satiety Response/drug effects , Administration, Intranasal , Adult , Brain/drug effects , Brain/metabolism , Drug Administration Schedule , Female , Food , Humans , Insulin/pharmacology , Male , Postprandial Period , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...